Sumatriptan

Study	Reference
De Jonge, 2013	de Jonge Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection. Drug Saf 2013; 36:1069-78
Ephross (Control exposed to Naratriptan), 2014	Ephross SA Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry. Headache 2014;54:1158-72
Kallen, 2001	Kallen Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001; 41:351-6
Källén (Controls exposed to ergots), 2011	K?ll?n B Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Saf 2011;34:691-703
Källén (Controls unexposed, disease free), 2011	Kallen B Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Saf 2011;34:691-703
Nezvalová-Henriksen (Control unexposed, disease free), 2013	Nezvalova-Henriksen K Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol 2013;28:759-69
Nezvalová-Henriksen (Control unexposed, sick), 2013	Nezvalova-Henriksen K Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol 2013;28:759-69
O'Quinn, 1999	O'Quinn Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch. Gynecol. Obstet. 1999; 263:7-12
Olesen (Control unexposed, disease free), 2000	Olesen C Pregnancy outcome following prescription for sumatriptan. Headache 2000;40:20-4
Olesen (Control unexposed, sick), 2000	Olesen C Pregnancy outcome following prescription for sumatriptan. Headache 2000;40:20-4
Shuhaiber (Control exposed to other treatments), 1998	Shuhaiber S Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998;51:581-3
Shuhaiber (Control unexposed, disease free), 1998	Shuhaiber S Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998;51:581-3
Spielmann (Control mainly exposed other treatments, sick), 2017	Spielmann K Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study. Cephalalgia 2017;:333102417724152
Spielmann (Control unexposed, disease free), 2017	Spielmann K Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study. Cephalalgia 2017;:333102417724152
Yusuf (Control exposed to Naratriptan), 2018	Yusuf Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study. Pharmacoepidemiol Drug Saf 2018; 27:1309-1315